Clinical Trial Update: Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous dendritic cells loaded with brain tumor stem cells for progressive malignant brain tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Ependymoma
• Glioblastoma
• Medulloblastoma

Drugs mentioned

• Dendritic cell vaccine loaded with brain tumor stem cells

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Brain Tumor, Glioblastoma | Phase 1 | Status: COMPLETED